Q3/2019: Financial Results
- Net sales increase by 8.1%, driven by double-digit growth in Healthcare and Life Science
- EBITDA pre up by 15.4%
- Forecast for sales and earnings raised following Versum acquisition
In the third quarter, we continued to resolutely implement our strategy. We substantially increased sales and earnings.
Related NewsView All News
Merck KGaA, Darmstadt, Germany generated strong organic sales growth and benefited from positive foreign exchange effects in the third quarter of 2019.